Challenger rejects Daiichi Life’s $4.4 billion takeover offer

Daiichi Life's Australian unit last week offered to buy the remaining 79.5% of Challenger at 11.80 Australian dollars per share.

Daiichi Life's Australian unit last week offered to buy the remaining 79.5% of Challenger at 11.80 Australian dollars per share.
No group discusses this yet. Start a discussion group and attach this story.